InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
2
T+90 hit rate
20%
T+90 mean return
-0.9%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by JANTZ DEREK, Directeur Scientifique. Officer active across 1 company, notably Precision Biosciences INC. Cumulatively, 7 reports have been published. Split: 0 buy · 2 sells. Total volume traded: €309k. Activity tracked since 12 May 2021. The latest transaction was filed on 17 May 2021 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations7 total
29,545 sharesCommon StockSEC:0001209191-22-035417:0
20,000 shares@ US$9.3849.5% of flowCommon StockSEC:0001209191-21-033864
20,000 shares@ US$9.380.15% mcap49.5% of flowCommon StockSEC:0001209191-21-033864:0
21,514 shares@ US$0.040.2% of flowCommon StockSEC:0001209191-21-033487
21,514 shares@ US$0.040.0007% mcap0.2% of flowCommon StockSEC:0001209191-21-033487:0
21,514 shares@ US$0.040.2% of flowCommon StockSEC:0001209191-21-032764
21,514 shares@ US$0.040.0007% mcap0.2% of flowCommon StockSEC:0001209191-21-032764:0
7 of 7 declarations
About JANTZ DEREK
Derek Jantz is the Chief Scientific Officer at Precision Biosciences Inc. He oversees the company's research and development initiatives, focusing on innovation in the biotechnology field. His role is crucial for the development of new therapies and scientific solutions. Precision Biosciences Inc. is known for its advancements in genome editing and stem cell-based treatments.
